The National Academies of Sciences, Engineering and Medicine has released a report summarizing its Sept. 5-6 workshop on medical product shortages during disasters and opportunities to better predict, prevent and respond to shortages. The Department of Health and Human Services asked NASEM to convene the workshop in response to the shortage of intravenous saline solution exacerbated by the 2017 hurricane season. AHA, which participated on the workshop planning committee, last year called for a comprehensive strategy to address these and other critical drug shortages. In July, Food and Drug Administration Commissioner Scott Gottlieb, M.D., convened an interagency task force to report to Congress on the root causes of drug shortages and recommend new federal authorities to address them. FDA will hold a public meeting Nov. 27 to receive stakeholder input on the issue.

Related News Articles

Headline
Reps. Scott Peters, D-Calif., Eliot Engel, D-N.Y., Brett Guthrie, R-KY, Anna Eshoo, D-Calif., Richard Hudson, R-N.C., Michael McCaul, R-Texas, Kurt Schrader, D…
Headline
The Food and Drug Administration today released a proposed rule that would allow states and other non-federal government entities to establish programs to…
Headline
Pictured, from left to right: Peter Adamson, chair of the Children’s Oncology Group at the Children’s Hospital of Philadelphia; Brian Marden, chief…
Headline
The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists and Institute for Safe…
Headline
The Food and Drug Administration approved a record high 1,171 generic drugs (935 full approvals and 236 tentative approvals) in fiscal year 2019, the agency…
Headline
The AHA and six other organizations today submitted comments to the Drug Enforcement Administration on its proposed rule regarding controlled substances quotas…